SG3 Management’s Tandem Diabetes Care TNDM Stock Holding History

SG3 Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-33,000	Closed	-$3.94M	–	1287
2021 Q3	$3.94M	Buy	+33,000	New	+$3.64M	0.12%	173

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SG3 Management's TNDM Position: Q4 2021 in Review

SG3 Management sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 3,000 shares — an estimated $358K sold.

SG3 Management first reported a position in TNDM in Q3 2021 and held it in 1 quarter. The position peaked at $358K in Q3 2021. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

SG3 Management reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
SG3 Management sold 3,000 Tandem Diabetes Care shares in Q4 2021, an estimated $358K.
SG3 Management first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 1 quarter.
SG3 Management's Tandem Diabetes Care position peaked at $358K in Q3 2021.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.